US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 7, 2024 (2 years ago)

Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications

What was recalled

Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62

Recalling firm
Teva Pharmaceuticals USA, Inc
NDC code
0093-2140-62
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0428-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Estradiol recalls

See all